Lea Surrey

24PUBLICATIONS
167CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesSolid tumoursComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.

|Apr 16, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.

|Sep 24, 2025
Reprogramming neuroblastoma by diet-enhanced polyamine depletion.

Sarah Cherkaoui, Christina S Turn, Yuan Yuan

|Aug 06, 2025
The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity.

John Maris, Isabel Soria-Bretones, Matias Casás-Selves

|Apr 14, 2025
Longitudinal single-cell multiomic atlas of high-risk neuroblastoma reveals chemotherapy-induced tumor microenvironment rewiring.

Wenbao Yu, Rumeysa Biyik-Sit, Yasin Uzun

|Jul 31, 2024
Identification and Characterization of Chemotherapy-Resistant High-Risk Neuroblastoma Persister Cells.

Liron D Grossmann, Chia-Hui Chen, Yasin Uzun

Pageof 4

Frequent Collaborators

4 joint publications

Theodore W Laetsch

4 joint publications

Oscar Lopez-Nunez

4 joint publications

John Maris

3 joint publications

David Groff